Human NK cells adhere to and lyse porcine endothelial cells (pEC) and there
fore may contribute to the cell-mediated rejection of vascularized pig-to-h
uman xenografts. Since MHC class I molecules inhibit the cytotoxic activity
of NK cells, the expression of HLA genes in pEC has been proposed as a pot
ential solution to overcome NK cell-mediated xenogeneic cytotoxicity. HLA-G
, a minimally polymorphic HLA class I molecule that can inhibit a wide rang
e of NK cells, is an especially attractive candidate for this purpose. In t
his study we tested whether the expression of HLA-G on pEC inhibits the mol
ecular mechanisms that lead to adhesion of human NK cells to pEC and subseq
uent xenogeneic NK cytotoxicity. To this end two immortalized pEC lines (2A
2 and PED) were stably transfected with HLA-GI. Rolling adhesion of activat
ed human NK cells to pEC monolayers and xenogeneic cytotoxicity against pEC
mediated by polyclonal human NK lines as well as NK clones were inhibited
by the expression of HLA-G. The adhesion was partially reversed by masking
HLA-G on pEC with anti-HLA mAbs or by masking the HLA-G-specific inhibitory
receptor ILT-2 on NK cells with the mAb HP-Fl. The inhibition of NK cytoto
xicity by HLA-G was only partially mediated by ILT-2,. indicating a role fo
r other unknown NK receptors. In conclusion, transgenic expression of HLA-G
may be useful to prevent human NK cell responses to porcine xenografts, bu
t is probably not sufficient on its own. Moreover, the blocking of rolling
adhesion by HLA-G provides evidence for a novel biological function of HLA
molecules.